C MYC translocation; Double hit lymphoma; Fine needle aspiration biopsy; Fluorescence in situ hybridization (FISH); IGH BCL2 translocation; Non Hodgkin lymphoma
Indexed keywords
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
METHOTREXATE;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
IMMUNOGLOBULIN HEAVY CHAIN;
KI 67 ANTIGEN;
MYC PROTEIN;
MYC PROTEIN, HUMAN;
ONCOPROTEIN;
PROTEIN BCL 2;
Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma
Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am J Clin Pathol. 1995;103:472-478.
Translocations involving 8q24 in burkitt lymphoma and other malignant lymphomas: A historical review of cytogenetics in the light of today's knowledge
Boerma EG, Siebert R, Kluin PM, Baudis M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia. 2009;23:225-234.
A biologic definition of burkitt's lymphoma from transcriptional and genomic profiling
Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419-2430.
Clinical relevance of bcl2 bcl6 and myc rearrangements in diffuse large b-cell lymphoma
Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152-3162.
4th Ed. Lyon France: International Agency For Research On Cancer
Swerdlow HS, Campo E, Harris NL, et al. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
B-cell lymphomas with concurrent igh-bcl2 and myc rearrangements are aggressive neoplasms with clinical and pathologic features distinct from burkitt lymphoma and diffuse large b-cell lymphoma
Snuderl M, Kolman OK, Chen Y, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34:327-340.
Adult b-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior
McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol. 2005;29:1652-1660.
Classifying b-cell non-hodgkin lymphoma by using mib-1 proliferative index in fine-needle aspirates
Ali AE, Morgen EK, Geddie WR, et al. Classifying B-cell non-Hodgkin lymphoma by using MIB-1 proliferative index in fine-needle aspirates. Cancer (Cancer Cytopathol). 2010;118:166-172.
Targeted use of fluorescence in situ hybridization (fish) in cytospin preparations: Results of 298 fine needle aspirates of b-cell non-hodgkin lymphoma
da Cunha Santos G, Ko HM, Geddie WR, et al. Targeted use of fluorescence in situ hybridization (FISH) in cytospin preparations: results of 298 fine needle aspirates of B-cell non-Hodgkin lymphoma. Cancer (Cancer Cytopathol). 2010;118:250-258.
Fluorescence in situ hybridization studies on direct smears: An approach to enhance the fine-needle aspiration biopsy diagnosis of b-cell non-hodgkin lymphomas
Monaco SE, Teot LA, Felgar RE, Surti U, Cai G. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer (Cancer Cytopathol). 2009;117:338-348.